1. Describe the rationale and design of the CHIP-BCIS 3 trial, including its patient population, methodology, and primary endpoints.
  2. Interpret the key findings and outcomes of the trial, particularly in relation to mortality, complications, and procedural safety.
  3. Evaluate the clinical implications of the trial results for contemporary interventional cardiology practice.
  4. Identify appropriate patient selection criteria for mechanical circulatory support during high-risk PCI.
Session date: 
04/17/2026 - 7:30am to 8:30am CDT
Add to calendar: 
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation
Please login or create an account to proceed.
Speaker Name: 
Dr. Mina Kerolos